Skip to main content
NCBI home page
EJVES Vascular Forum logoLink to EJVES Vascular Forum
editorial
. 2024 Feb 9;61:89–91. doi: 10.1016/j.ejvsvf.2024.02.001

EJVES Vascular Forum Moves Forward

Melina Vega de Ceniga 1,2,3,∗, Arindam Chaudhuri 4
PMCID: PMC10912046  PMID: 38444727

The EJVES Vascular Forum (EJVESVF) was reborn in 2020, with the ambition to take the second European Society for Vascular Surgery (ESVS) peer reviewed, open access, online only journal to the next level.1 In four years, the journal has developed from a hub of case reports to a platform that publishes full original research papers,2 reviews,3 short and case reports,4 technical notes,5 invited commentaries,6 and abstracts from ESVS meetings, with additional special support of audiovisual material, images7 and surgical videos.8 Submissions have increased from 119 in 2018 to an all time high of 185 in 2021. Published papers have also increased from 41 in 2018 to 56 in 2022 (Fig. 1). The rejection rate remains stable at 60–65%, with an increase in the percentage of fast track initial editorial screening, thus shortening the decision times.

Figure 1.

Figure 1

Open in a new tab

Number of submissions and published papers per year in European Journal of Vascular and Endovascular Surgery Short Reports (2016–2019) and EJVES Vascular Forum (2020–2023).

There have been other significant changes in the journal. The volumes remain open, and papers are published online and within the volume as soon as the proofs are ready, so median time from acceptance to first publication is as little as six days and 27 days to final publication, which adds to fast reader access to the information and author satisfaction. The number of yearly volumes has been reduced from four to two, as this speedy and continuous line of publication does not require compilation of volumes and issues. Another novelty is the special issues and article collections, where readers can find monographs on specific topics. Two collections of papers published in EJVESVF in 2020–2023 have been released so far, gathering the most updated information on vascular graft science (https://www.sciencedirect.com/journal/ejves-vascular-forum/special-issue/105HMCVLP79) and vascular infection (https://www.sciencedirect.com/journal/ejves-vascular-forum/special-issue/10K41HCM0KT).

The team making EJVESVF possible is small and diverse.9 It also allows the flexibility of inviting temporary Assistant Editors (https://www.ejvesreports.com/article/S2666-688X(23)00089-8/pdf) for specific initiatives, like the live forum events held monthly in 2021–2023 on the journal's webpage. It is through strong team effort that all the regular journal work is completed, and new initiatives come to happen. We are also extremely grateful for the altruistic and often insufficiently recognised work of our reviewers, who help the authors make their papers shine.10 In the period 2020–2023, 170 unique reviewers performed 1 254 reviews for EJVESVF. We make a point of finding and training young new reviewers, to refresh and rejuvenate the pool of experts, always being mindful of potential and quality, but also diversity and equality. The Editorial Board is a way of recognising the best and most active reviewers, and it has also been updated during this editorial term.

EJVESVF has proven to be an excellent platform for innovation. Our clear stake for audiovisual communication has enabled the development of the visual abstract program (Fig. 2), first in EJVESVF (https://www.ejvesreports.com/content/visual_abstracts) and now also in the sister journal, the European Journal of Vascular and Endovascular Surgery, and the ESVS podcasts,11 which have already branched out into an independent committee within the ESVS (https://esvs.org/esvs-podcasts-2/). Since the beginning of the program in late 2019, the ESVS podcasts have released 125 tracks, accumulated over 33 000 downloads by about 3 000 different listeners and currently have more than 1 080 followers. The podcasts started within the EJVESVF and have become a signature feature of the ESVS. This has now moved to separate web based audio platforms.

Figure 2.

Figure 2

Open in a new tab

Visual abstract from an original research paper15 published in European Journal of Vascular and Endovascular Surgery Vascular Forum.

Social media has been closely intertwined with the EJVESVF activities.12 This was from the inception of social media as an important journal adjunct,13 helping to boost the online presence of the EJVESVF,14 in addition to linking podcasts via platforms such as SoundCloud, which could be directly accessed via Twitter (now X). This will have additional exposure via LinkedIn from now on.

Without a doubt, the highlight of the last four years has been the achievement of the Journal Impact Factor (JIF) in June 2023.9 The journal's CiteScore has continuously been increasing since 2016, reaching 1.1 in 2021. The journal was then included in the Emerging Sources Citation Index in 2022, and finally obtained its first JIF, 0.6, in 2023. This is an important asset for authors who seek academic recognition and a landmark for the journal.

A new phase of EJVESVF begins. Editor in chief Melina Vega de Ceniga, who marshalled the significant evolution of the journal into its current form, handed over the management to Arindam Chaudhuri in January 2024. Arindam steps in with fresh ideas and enthusiasm, and the journal moves forward to the next stage. New initiatives in the pipeline include the addition of a flipbook for each volume, the development of a video program, and initiatives to improve the visibility of the journal to readers and authors. The position comes with inherent challenges on managing a multimedia platform and balancing high scientific standards and cutting edge innovation. Arindam and his team will strive to give authors and readers the best educational experience there is to offer. Moving forward, the future is bright.

References

  • 1.Vega de Ceniga M., Ricco J.-B. Rebirth of an ESVS journal: the new and interactive EJVES Vascular Forum. Eur J Vasc Endovasc Surg. 2020;59:3–4. doi: 10.1016/j.ejvs.2019.12.001. [DOI] [PubMed] [Google Scholar]
  • 2.Mandigers T.J., Conti M., Allievi S., Dedola F., Bissacco D., Bianchi D., et al. Comparison of two generations of thoracic aortic stent grafts and their impact on aortic stiffness in an ex vivo porcine model. EJVES Vasc Forum. 2023;59:8–14. doi: 10.1016/j.ejvsvf.2023.04.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lejay A., Bratu B., Kuntz S., Neumann N., Heim F., Chakfé N. Calcification of synthetic vascular grafts: a systematic review. EJVES Vasc Forum. 2023;60:1–7. doi: 10.1016/j.ejvsvf.2023.05.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kontopodis N., Tzirakis K., Tzartzalou I., Ioannou C.V. Comparison of the haemodynamic performance of various treatment options for aorto-iliac occlusive disease. EJVES Vasc Forum. 2023;60:24–27. doi: 10.1016/j.ejvsvf.2023.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lareyre F., Caradu C., Chaudhuri A., Lê C.D., Di Lorenzo G., Adam C., et al. Automatic detection of visceral arterial aneurysms on computed tomography angiography using artificial intelligence based segmentation of the vascular system. EJVES Vasc Forum. 2023;59:15–19. doi: 10.1016/j.ejvsvf.2023.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.van der Vorst J.R., Teraa M. Calcified pseudocoarctation after thoracic endovascular aortic repair: a hard case to crack. EJVES Vasc Forum. 2023;60:82–83. doi: 10.1016/j.ejvsvf.2023.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang Y-s, Li D-l. Severe calcification and stenosis of the entire inferior vena cava in a patient with Budd-Chiari syndrome and hypoparathyroidism. EJVES Vasc Forum. 2023;59:20. doi: 10.1016/j.ejvsvf.2023.05.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Debus E.S., Malik K., Kölbel T., Honig S., Brickwedel J., Behem C., et al. First in human implantation of the thoracoflo graft: a new hybrid device for thoraco-abdominal aortic repair. EJVES Vasc Forum. 2023;58:28–31. doi: 10.1016/j.ejvsvf.2023.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Vega de Ceniga M., Chaudhuri A. EJVES Vascular Forum gets a journal impact factor, not just a JIFfy. Eur J Vasc Endovasc Surg. 2023;66:155–157. doi: 10.1016/j.ejvs.2023.07.015. [DOI] [PubMed] [Google Scholar]
  • 10.Vega de Ceniga M., Marcos F.A., Koelemay M. Acknowledgement to reviewers. EJVES Vasc Forum. 2023:60. [Google Scholar]
  • 11.Vega de Ceniga M., Kavaliunaite E. ESVS podcasts: connecting with the world. EJVES Vasc Forum. 2023;58:13–14. doi: 10.1016/j.ejvsvf.2023.01.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Vega de Ceniga M., Chaudhuri A. Learn, connect, and interact with the EJVES: EJVES vascular forum and @EJVES_ESVS. Eur J Vasc Endovasc Surg. 2020;60:335–336. doi: 10.1016/j.ejvs.2020.07.070. [DOI] [PubMed] [Google Scholar]
  • 13.Chaudhuri A. European Journal of Vascular and Endovascular Surgery in the era of social media. Eur J Vasc Endovasc Surg. 2014;47:679. doi: 10.1016/j.ejvs.2014.02.019. [DOI] [PubMed] [Google Scholar]
  • 14.Chaudhuri A., Prendes C.F. Social media and EJVES 2013–2023: from inception to evolution. Eur J Vasc Endovasc Surg. 2023;65:769–771. doi: 10.1016/j.ejvs.2023.04.012. [DOI] [PubMed] [Google Scholar]
  • 15.Panthofer A.M., Olson S.L., Rademacher B.L., Kraiss L.W., Blackwelder W.C., Baxter B.T., et al. Effect of two years of doxycycline treatment on infrarenal aortic neck diameter. EJVES Vasc Forum. 2023;59:43–48. doi: 10.1016/j.ejvsvf.2023.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from EJVES Vascular Forum are provided here courtesy of Elsevier

RESOURCES